Target intelligence / Profile preview

Ovostatin 1 pseudogene (OVOS1P)

Target
OVOS1P
Molecular classification
Other (Pseudogene)
01

Overview

OVOS1P, or ovostatin 1 pseudogene, is a **pseudogene** related to the ovostatin family of protease inhibitors[4][6][7]. The functional ovostatin (not the pseudogene) is a large, tetrameric protein originally isolated from chicken egg white, known for its ability to inhibit metalloproteases and acid proteases through a unique trapping mechanism[1][5]. However, OVOS1P and related pseudogenes do not encode functional proteins and are not considered enzymes, receptors, or drug targets. The "pseudogene" status means it is a non-functional, non-coding remnant of a gene and lacks biological or therapeutic activity[7][6]. Therefore, "ovostatin 1, pseudogene" should not be considered a therapeutic target. Note: There may be confusion due to the overlap with functional ovostatin proteins (e.g., OVM, ovomacroglobulin), which are legitimate protease inhibitors with structural and functional similarity to alpha-2-macroglobulin[1][5]. However, the "pseudogene" form is non-functional and is not a valid target for drug discovery or therapeutic intervention.

Other names
OVMovomacroglobulinOvostatin pseudogeneOvostatin (OVOS) pseudogene

Beyond the preview

Go deeper on Ovostatin 1 pseudogene (OVOS1P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovostatin 1 pseudogene (OVOS1P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call